Educational content on VJOncology is intended for healthcare professionals only. By visiting this website and accessing this information you confirm that you are a healthcare professional.

Discover the latest research and hot topics in urology at EAU 2023

EAU 2023

European Association of Urology Annual Meeting 2023
10–13 March 2023 | Milan, Italy

EAU 2023

European Association of Urology Annual Meeting 2023
10–13 March 2023 | Milan, Italy
Discover the latest research and hot topics in urology at EAU 2023
Photodynamic surgery as a diagnostic and therapeutic approach for bladder cancer 1:00
Photodynamic surgery as a diagnostic and therapeutic approach for bladder cancer
Rakesh Heer • 27 May 2023
Effectiveness of photodynamic assessments in non-muscle invasive bladder cancer: real-life study 2:19
Effectiveness of photodynamic assessments in non-muscle invasive bladder cancer: real-life study
Rakesh Heer • 27 May 2023
A randomized trial of PHOTOdynamic surgery in non–muscle-invasive bladder cancer 1:02
A randomized trial of PHOTOdynamic surgery in non–muscle-invasive bladder cancer
Rakesh Heer • 27 May 2023
Exploring the clinical and economic impact of PDD in NMIBC: findings, implications, and future steps 0:38
Exploring the clinical and economic impact of PDD in NMIBC: findings, implications, and future steps
Rakesh Heer • 27 May 2023
Photodynamic diagnosis in NMIBC: insights and impact of blue light surgery on recurrence rates 2:01
Photodynamic diagnosis in NMIBC: insights and impact of blue light surgery on recurrence rates
Rakesh Heer • 27 May 2023
Safety of prostate-sparing + reproductive organ-sparing radical cystectomy for MIBC 1:40
Safety of prostate-sparing + reproductive organ-sparing radical cystectomy for MIBC
Carmen Mir Maresma • 15 Mar 2023
ZIRCO: 89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma 2:17
ZIRCO: 89Zr-DFO-girentuximab for PET/CT imaging of clear cell renal cell carcinoma
Carmen Mir Maresma • 15 Mar 2023
Best of EAU23: renal cancer 2:26
Best of EAU23: renal cancer
Carmen Mir Maresma • 15 Mar 2023
From conventional to molecular diagnostics for prostate cancer 1:38
From conventional to molecular diagnostics for prostate cancer
Eva Compérat • 7 Mar 2023
Subtypes of prostate cancer and how they change our management 1:59
Subtypes of prostate cancer and how they change our management
Eva Compérat • 7 Mar 2023
How to manage active surveillance in 2023: minimal requirements for histopathology of biopsies 2:48
How to manage active surveillance in 2023: minimal requirements for histopathology of biopsies
Eva Compérat • 7 Mar 2023
EU Cancer Plan and what it means for prostate cancer 5:35
EU Cancer Plan and what it means for prostate cancer
Tit Albreht • 29 Mar 2023
Towards the delivery of comprehensive cancer centers – what it means for prostate cancer 3:00
Towards the delivery of comprehensive cancer centers – what it means for prostate cancer
Tit Albreht • 29 Mar 2023
Which populations should be screened for prostate cancer? 1:10
Which populations should be screened for prostate cancer?
Tit Albreht • 29 Mar 2023
PARP inhibitors for metastatic hormone sensitive prostate cancer 3:47
PARP inhibitors for metastatic hormone sensitive prostate cancer
Bertrand Tombal • 17 Mar 2023
Predictors of response to surgery for penile cancer 1:16
Predictors of response to surgery for penile cancer
Philippe Spiess • 10 Mar 2023
The content of VJOncology is intended for healthcare professionals